Maryland's Premier Medtech Venture Capital Firm

Ecphora’s vision is to establish Maryland as the global epicenter for medical commercialization, advancing groundbreaking innovations that transform medicine and healthcare worldwide

$30M+

invested

15

portfolio companies

15

years our founder has spent in the BioHealth Capital Region

Ways to work with us

For founders

Raising a round? We help Maryland medtech companies bring their investors together in one Ecphora-managed vehicle.

For fund managers

Ready to launch your own fund? Ecphora covers the setup costs and serves as co-GP so you can focus on investing.

For investors

Already invested with us? Log in to the investor portal for documents, K-1s and updates.

Medical device icon

Medical Device

Tech-enabled medical devices poised to revolutionize healthcare systems, processes, and patient treatment worldwide.

Biotech icon

Biotech

Pioneering novel therapies, precision medicine, gene editing, and regenerative medicine ventures to reshape the future of disease treatment.

Digital health icon

Digital Health

Leveraging data analytics, AI, telemedicine, and remote patient monitoring to improve healthcare access, efficiency, and outcomes on a global scale.

HealthTech icon

HealthTech

Improving every part of the healthcare system by streamlining operations and communication across the entire ecosystem.

Ecphora Capital logo
Baltimore Inner Harbor skyline at night

The BioHealth Capital Region

World-class IP and overflowing with innovation from top-tier medical and research institutions. We have spent over a decade in the region giving our firm unprecedented access to the most promising biomedical tech startups.

Experienced Team

Ecphora Capital is led by the visionary entrepreneur and investor Deborah Hemingway, Ph.D. and an extended team of seasoned professionals with extensive expertise in venture capital, startup scaling, strategic growth, and the medtech ecosystem.

Researchers working at a microscope in a lab

Get our newsletter

News and perspective on Maryland medtech from Deborah Hemingway, PhD.